These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37712527)

  • 21. THE GLOBAL POINT PREVALENCE SURVEY (PPS) OF ANTIMICROBIAL USE AND ANTIMICROBIAL RESISTANCE AMONG HOSPITALIZED CHILDREN IN GEORGIA.
    Korinteli IG; Mchedlishvili I; Javakhadze M; Versporten A; Goossens H; Phagava H; Pagava K
    Georgian Med News; 2019; (292-293):72-75. PubMed ID: 31560667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-Year Point Prevalence Survey of Antimicrobial Use in a Chinese University Hospital.
    Jing FH; Wang Q; He TJ; Xin N; Wang YW; Han Y; Wang X; Li Z
    Can J Infect Dis Med Microbiol; 2024; 2024():6698387. PubMed ID: 38361762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.
    Versporten A; Zarb P; Caniaux I; Gros MF; Drapier N; Miller M; Jarlier V; Nathwani D; Goossens H;
    Lancet Glob Health; 2018 Jun; 6(6):e619-e629. PubMed ID: 29681513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point prevalence survey of antimicrobial prescription in a tertiary hospital in South East Nigeria: A call for improved antibiotic stewardship.
    Umeokonkwo CD; Madubueze UC; Onah CK; Okedo-Alex IN; Adeke AS; Versporten A; Goossens H; Igwe-Okomiso D; Okeke K; Azuogu BN; Onoh R
    J Glob Antimicrob Resist; 2019 Jun; 17():291-295. PubMed ID: 30668994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial Usage and Resistance in Makkah Region Hospitals: A Regional Point Prevalence Survey of Public Hospitals.
    Haseeb A; Faidah HS; Algethamy M; Alghamdi S; Alhazmi GA; Alshomrani AO; Alqethami BR; Alotibi HS; Almutiri MZ; Almuqati KS; Albishi AA; Elrggal ME; Mahrous AJ; Khogeer AA; Saleem Z; Iqbal MS; Sheikh A
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicentre point-prevalence survey of antibiotic use and healthcare-associated infections in Ethiopian hospitals.
    Fentie AM; Degefaw Y; Asfaw G; Shewarega W; Woldearegay M; Abebe E; Gebretekle GB
    BMJ Open; 2022 Feb; 12(2):e054541. PubMed ID: 35149567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point prevalence survey of antibiotics use among hospitalised neonates and children in Saudi Arabia: findings and implications.
    Alosaimi HM; Alshammari MK; Fetyani MM; Allehidan MS; Almalki TJ; Hussain KH; Hussain HH; Althobaiti MD; Alharbi AS; Alharthi AA; Al-Shammari AA; Al Jamea ZA; Alamro RA; Najmi A
    J Pharm Policy Pract; 2024; 17(1):2371411. PubMed ID: 39011353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Point Prevalence Survey of Antimicrobial Use and Resistance during the COVID-19 Era among Hospitals in Saudi Arabia and the Implications.
    Haseeb A; Abuhussain SSA; Alghamdi S; Bahshwan SM; Mahrous AJ; Alzahrani YA; Alzahrani AF; AlQarni A; AlGethamy M; Naji AS; Khogeer AAO; Iqbal MS; Godman B; Saleem Z
    Antibiotics (Basel); 2023 Nov; 12(11):. PubMed ID: 37998811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic Prescribing Patterns in Ghana, Uganda, Zambia and Tanzania Hospitals: Results from the Global Point Prevalence Survey (G-PPS) on Antimicrobial Use and Stewardship Interventions Implemented.
    D'Arcy N; Ashiru-Oredope D; Olaoye O; Afriyie D; Akello Z; Ankrah D; Asima DM; Banda DC; Barrett S; Brandish C; Brayson J; Benedict P; Dodoo CC; Garraghan F; Hoyelah J; Jani Y; Kitutu FE; Kizito IM; Labi AK; Mirfenderesky M; Murdan S; Murray C; Obeng-Nkrumah N; Olum WJ; Opintan JA; Panford-Quainoo E; Pauwels I; Sefah I; Sneddon J; St Clair Jones A; Versporten A
    Antibiotics (Basel); 2021 Sep; 10(9):. PubMed ID: 34572704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications.
    Ogunleye OO; Oyawole MR; Odunuga PT; Kalejaye F; Yinka-Ogunleye AF; Olalekan A; Ogundele SO; Ebruke BE; Kalada Richard A; Anand Paramadhas BD; Kurdi A; Sneddon J; Seaton A; Godman B
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):297-306. PubMed ID: 34128756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of healthcare-associated infections and antimicrobial use among inpatients in a tertiary hospital in Fiji: a point prevalence survey.
    Loftus MJ; Curtis SJ; Naidu R; Cheng AC; Jenney AWJ; Mitchell BG; Russo PL; Rafai E; Peleg AY; Stewardson AJ
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):146. PubMed ID: 32859255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence and pattern of antibiotic prescription among insured patients in Dar es Salaam Tanzania.
    Khalfan MA; Sasi PG; Mugusi SF
    Pan Afr Med J; 2021; 40():140. PubMed ID: 34909108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe.
    Zarb P; Goossens H
    Drugs; 2011 Apr; 71(6):745-55. PubMed ID: 21504250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic use and quality indicators of antibiotic prescription in Bhutan: a point prevalence survey using the Australian National Antimicrobial Prescribing Survey tool.
    Chuki P; Dorji T; James R; Wangchuk K; Yangzom S; Dema Y; Wangchuk S; Wangdi D; Deki T; Limbu C; Dorji KR; Wangda S; Buising K; Thursky K
    JAC Antimicrob Resist; 2023 Aug; 5(4):dlad100. PubMed ID: 37614960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Point-prevalence survey of antimicrobial use in intensive care units in Nepal.
    Koirala S; Dahal A; Paneru HR; Thapa A; Bhusal S; Shakya R; Luitel S; Koirala K; Aryal D
    Antimicrob Steward Healthc Epidemiol; 2024; 4(1):e78. PubMed ID: 38721494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-infections and antimicrobial use among hospitalized COVID-19 patients in Punjab, Pakistan: findings from a multicenter, point prevalence survey.
    Mustafa ZU; Saleem MS; Ikram MN; Salman M; Butt SA; Khan S; Godman B; Seaton RA
    Pathog Glob Health; 2022 Oct; 116(7):421-427. PubMed ID: 34783630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A repeated point prevalence survey of antimicrobial use in specialized cancer care hospital of Pakistan: findings and implications.
    Saleem Z; Hassali MA; Hashmi FK; Godman B; Bhutta OA
    Hosp Pract (1995); 2019 Aug; 47(3):149-154. PubMed ID: 31180791
    [No Abstract]   [Full Text] [Related]  

  • 38. Antimicrobial use in hospitalized patients: a multicentre point prevalence survey across seven hospitals in Ghana.
    Labi AK; Obeng-Nkrumah N; Dayie NTKD; Egyir B; Sampane-Donkor E; Newman MJ; Opintan JA
    JAC Antimicrob Resist; 2021 Sep; 3(3):dlab087. PubMed ID: 34263166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Point-prevalence surveys of antimicrobial consumption and resistance at a paediatric and an adult tertiary referral hospital in Yangon, Myanmar.
    Oo WT; Carr SD; Marchello CS; San MM; Oo AT; Oo KM; Lwin KT; Win HH; Crump JA
    Infect Prev Pract; 2022 Mar; 4(1):100197. PubMed ID: 35005602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point Prevalence Survey of Antibiotic Use across 13 Hospitals in Uganda.
    Kiggundu R; Wittenauer R; Waswa JP; Nakambale HN; Kitutu FE; Murungi M; Okuna N; Morries S; Lawry LL; Joshi MP; Stergachis A; Konduri N
    Antibiotics (Basel); 2022 Feb; 11(2):. PubMed ID: 35203802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.